 |
14-amino acid peptide derived from wound growth factor |
|---|---|
| Trade Name | |
| Orphan Indication | Prevention of delayed graft function in renal transplant recipients |
| USA Market Approval | USA |
| USA Designation Date | 2010-08-05 00:00:00 |
| Sponsor | NephRx Corporation;4717 Campus Drive;Kalamazoo, Michigan, 49008 |
